Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2014; 20(2): 384-400
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.384
Figure 4
Figure 4 Peptide YY-immunoreactive cells. A: In the colon of a healthy subject; B: In a patient with irritable bowel syndrome (IBS). The density of peptide YY cells in the colon is lower in IBS patients than in healthy controls.